Corpus Intelligence IC Memo — PETERSON REGIONAL MEDICAL CENTER 2026-04-26 05:27 UTC
IC Memo — PETERSON REGIONAL MEDICAL CENTER
Investment Committee Memorandum | TX | 98 beds | Grade C | EBITDA uplift $11.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PETERSON REGIONAL MEDICAL CENTER

CCN 450007 | KERR, TX | 98 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PETERSON REGIONAL MEDICAL CENTER is a 98-bed suburban community hospital in KERR, TX with $156.8M in net patient revenue and a -9.9% operating margin. The hospital serves a payer mix of 39.9% Medicare, 1.0% Medicaid, and 59.1% commercial.

Thesis: Turnaround. Our ML models identify $11.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -9.9% to -2.6% (+736bps).

Net Revenue HCRIS$156.8M
Current EBITDA COMPUTED$-15.6M
Operating Margin COMPUTED-9.9%
Occupancy HCRIS45.5%
Revenue / Bed COMPUTED$1.6M
Net-to-Gross HCRIS22.7%
Distress Probability ML47.5%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
194
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of -9.9% places it below the state median. Among 194 size-comparable peers (49-196 beds), the median margin is 2.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (49-196), prioritizing same-state peers. 194 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PETERSON REGIONAL MEDICAL CENT (Target)TX98$156.8M-9.9%
ROUND ROCK HOSPITALTX165$681.4M8.7%
THE HEART HOSPITAL BAYLOR PLANTX109$464.6M25.7%
COVENANT CHILDRENS HOSPITALTX181$410.3M15.5%
COLLEGE STATION HOSPITALTX135$397.7M-0.9%
MEMORIAL HERMANN KATYTX196$381.4M13.3%
CHILDRENS HOSPITAL OF SAN ANTOTX174$376.5M-2.8%
DECATUR COMMUNITY HOSPITALTX81$361.0M-15.5%
CHILDRENS MEDICAL CENTER OF PLTX72$336.7M20.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.3M+210bp18mo
Cost to Collect4.5%2.5%$3.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.9M+122bp9mo
Clean Claim Rate88.0%96.0%$100K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.3M
Cost to Collect
$3.1M
Denial Rate Reduction
$3.1M
A/R Days Reduction
$1.9M
Clean Claim Rate
$100K
Total EBITDA Uplift$11.5M
Current EBITDA$-15.6M
+ RCM Uplift+$11.5M
Pro Forma EBITDA$-4.1M
Current Margin-9.9%
Pro Forma Margin-2.6%
WC Released (1x)$6.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-24.0M$12.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-24.0M$6.0M0.00x-100.0%
Bull Case9.0x11.0x$-21.6M$36.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-21.6M$33.2M0.00x-100.0%
Bear Case11.0x10.0x$-26.4M$-37.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-26.4M$-49.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 194 hospitals with 49-196 beds
  • Same-state prioritization (n=195)
  • Comp margins: P25=-9.6% / P50=2.8% / P75=13.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.